EU Reference Laboratories for Public Health – 2026 Calls for Applications

EU Reference Laboratories for Public Health – 2026 Calls for Applications

This opportunity is an official European Commission consultation and call page for the designation of EU Reference Laboratories (EURLs) in public health. The current 2026 consultation is publicly marked as Open. The page lists an opening date of 11 March 2026 and a submission deadline of 19 August 2026, 12:00 (CEST). It is a 2026 cycle call that sits in the EU public-health infrastructure track, with a long-term relevance to 2026/2027 because the selected labs become EU-level nodes in disease surveillance, testing harmonisation, and outbreak support across years.

This is not a typical short-term stipend or one-off award announcement. Instead, it is a designation process for ECDC-coordinated laboratory infrastructure under Regulation (EU) 2022/2371. The goal is to strengthen cross-border public-health readiness through authoritative reference methods, shared quality standards, and improved pathogen monitoring.

Key details

What this opportunity is and why it is still relevant

The 2026 page makes two points important for planning: first, this is a recurring, structured process, not a one-time program; second, there are now at least two prior waves (2023, 2024, 2025) and this 2026 wave is the newest round. That pattern is significant for applicants because it signals process maturity and an established expectations profile. If your lab has participated in earlier calls, much of your internal preparation can be reused and improved rather than rewritten.

The opportunity is not only about funding. The Commission frames it as a designation process in which applicants are assessed for their capacity to coordinate tasks like external quality assessment, diagnostics harmonisation support, surveillance methods, outbreak response support, and training. The same call page explicitly says that EURLs support national reference labs and national surveillance systems; that means operational fit matters as much as scientific quality.

Why this matters for applicants in 2026/2027:

• It is infrastructure-oriented and role-specific, not an open-ended proposal mechanism.
• Selection is competitive and tied to designated tasks.
• Even if not funded now, your institution gains a repeat-cycle signal on where standards and topics are converging in EU public health.

This makes it a strategic filing for national laboratories, major public-health institutions, and institutional consortia that already work across borders.

What is actually being called in 2026

The consultation page lists four separate calls under the 2026 wave:

1. EURL for Public Health on Clostridioides difficile
2. EURL for Public Health on Sexually Transmitted Bacteria
3. EURL for Public Health on Mycobacteria
4. EURL for Public Health on Invasive Bacteria

The page provides per-topic terms documents, annexes, and an online application form link. A separate guidance document is also maintained and was last updated on 12 May 2026.

At the level of official facts visible on the page:

• The page is explicitly open and open to the public, with the standard EU consultation header.
• It is positioned as an ongoing cycle from the 2026 announcement series.
• The call is framed in the context of Regulation (EU) 2022/2371, which created legal duties around EU reference laboratories.

For 2026, this means the applicant can treat one page as the programme entry and branch into topic-specific ToR documents when selecting the pathogen area.

Who should consider applying

This opportunity is strongest for organisations that can credibly perform coordination and service functions at EU level.

A good applicant profile usually includes:

• National public-health labs with active microbiology, infection control, and surveillance portfolios.
• Institutions that already interact with ECDC systems or national disease networks.
• Labs with established quality-management systems and documented proficiency in relevant testing frameworks.
• Organisations that can absorb operational coordination tasks and sustain a team across administrative, technical, and communication functions.
• Institutions willing to align with ECDC requirements and submit through formal endorsement and technical templates.

Even strong research labs without direct national network integration often fail when they lack practical coordination depth. The position is not simply “can you do testing,” but “can you coordinate a network role in a standardized EU context.”

The STB Terms of Reference confirms this operational orientation directly:

• Language is English.
• The call supports coordinated lab networks for surveillance, testing standards, and data quality.
• Applications can be submitted by a single laboratory or a consortium.
• The designation period is multi-year and subject to review.

If you are a university department lab with mostly academic outputs and no formal public-health deployment links, this may be a harder fit than a national reference centre, regional public-health lab, or a consortium combining lab and public-health authority assets.

Eligibility, scoring, and constraints that are easy to miss

The most common issue is treating this as a normal grant where a short concept note is enough. The STB call document reveals the call behaves more like a formal designation with explicit structure and technical annexing.

Core practical constraints to verify early

• Applicant profile: EU/EEA location and microbiology relevance for the selected pathogen topic.
• Language: English-only working language for the call.
• Sponsorship / endorsement: national competent authority endorsement is required and part of the application process.
• Single application rule per lab per topic: the STB call explicitly warns the same lab should not apply more than once per topic and not as both solo and consortium applicant for that topic.
• No preparatory reimbursement: no budget support for preparing and submitting the application itself.
• Competition structure: publication → application preparation → evaluation → designation, with only designated applicants advancing to funded operational support.

Selection mechanics (what evaluators actually score)

The STB terms explain a 100-point framework in four criteria groups with thresholding behavior (each criterion has minimum pass expectations). In practical terms this means:

• If you score high in only one area but weakly in another, you can still fail.
• Reviewers care about both role understanding and execution capacity.
• Team and coordination evidence is not optional; it is weighted.

For applicants, this shifts writing priorities:

• Explain role logic against EU/public-health architecture.
• Show why your team can own cross-institution work.
• Demonstrate quality systems, network coordination processes, and operational governance.

Common mistake pattern

1. Underestimating endorsement workload (missing or weak formal national backing).
2. Overstating scientific claims while under-documenting coordination capacity.
3. Submitting templates with language and formatting mismatches.
4. Treating this like a one-year project grant instead of a designated reference function.

Application process: sequence to follow

The page and ToR documents indicate this process:

1. Choose the pathogen track (one of four topics).
2. Download official ToR and annexes for that topic.
3. Engage national competent authority early for endorsement requirements.
4. Build a full application package including the technical description and workplan.
5. Submit by 19 Aug 2026, 12:00 CEST.
6. Expect evaluation in late summer / early autumn 2026 and formal results communication in September 2026.

Why the STB ToR is useful even beyond STB

The STB PDF is the most complete public artifact available in this cycle, and it gives strong process signals:

• publication and key milestones
• candidate/consortium structures
• endorsement flow
• criteria and scoring architecture
• designation outcomes and follow-up mechanics

For the other three topics, the consultation page points to corresponding terms and annexes, and the process is expected to mirror these mechanics.

Recommended preparation timeline (minimum)

• Now to mid-May 2026: map strategic fit by topic and secure preliminary internal ownership.
• Mid-May to mid-June: draft the technical workplan and collect endorsement evidence paths.
• Late June to mid-July: align with partner labs (if consortium route) and complete role ownership map.
• Late July: hard stop for first full draft review.
• Final two weeks pre-deadline: finalize annexes, naming, and compliance checks, then submit.

Official links to use

• Official opportunity page (entry point): https://health.ec.europa.eu/consultations/eu-reference-laboratories-public-health-2026-calls-applications_en
• Terms of reference for one 2026 topic (Sexually Transmitted Bacteria): https://health.ec.europa.eu/document/download/e4cea08d-b8bd-4c12-8e00-e1724eb937b1_en?filename=security_eurl_2026-call_stb_tor_en.pdf
• Online form entry used by the listing for one topic: https://ec.europa.eu/eusurvey/runner/EURL-PH-CDiff
• Guidance document on the same page (updated 12 May 2026)

If your team is preparing another topic, use the consultation hub to select the right topic terms and forms before opening application drafting.

What the funding likely covers and what is unknown

The amount is not explicitly shown in the hub listing. That alone is a reason to treat this as a “designation-linked support framework” instead of a conventional cost-line grant page. The page and STB ToR structure indicate financial support exists for designated EURLs, but the published headline page does not give a simple single budget box.

In practice, use this approach:

• If you need raw funding amount for institutional planning, wait for the topic-specific terms and annexes plus subsequent award communications.
• Treat this as an institutional commitment + operation support opportunity rather than simple cash-only support.
• Build proposal budgets around required operational functions: coordination, quality activities, method development, training support, and reporting.

When a call is this operational, the strongest applications are those that present governance and execution plans even before unit-level budget lines are scrutinized.

Fit decision framework: how to decide whether to apply

Before filing, answer these with evidence:

• Do we already support EU-aligned microbiology operations in the disease domain?
• Can we coordinate with national focal points and external labs?
• Do we have documented training, quality assurance, and data harmonization practices?
• Can we sustain at least annual/biannual activities at the level expected from a reference node?
• Have we secured national-level endorsement commitments before submission?

If you have two or more weak answers, consider delaying and partnering with a stronger national entity. For consortium applicants, this is usually the better route than forcing a solo application.

Who should not apply

• Labs entering microbiology only as a side programme without dedicated public-health service responsibilities.
• Institutions without national mandate links.
• Applicants hoping for simple reimbursement without long-term coordination obligations.
• Teams that cannot submit a complete package in English with all required official templates.

Common pitfalls and reviewer expectations

Reviewers for designation calls tend to score consistency and reliability higher than novelty.

Pitfalls

• Overpromising tasks that are operationally impossible under existing staffing and governance.
• Weak endorsement chain.
• Missing mandatory annexes.
• Not using official templates and naming conventions from the ToR.

Reviewer expectations

• Alignment of the application with the legal and practical role in Regulation (EU) 2022/2371.
• Demonstrated ability to support national labs, surveillance and quality harmonization.
• Clear governance model, including links to ECDC/national systems.
• Realistic implementation plan with measurable outputs and workload estimates.

FAQ

Is this an individual scholarship or grant for students?

No. This is a public-health designation process for laboratories and institutions, focused on service and coordination functions.

Is it too early to apply if the deadline is in August?

The call is already open and visible, with an explicit deadline. The key is whether your institution can produce a complete official package by submission day.

Can a consortium apply?

Yes. The STB Terms make it clear a single lab or consortium may apply, with the caveat each participant must respect the rules per topic.

Where do I find the official requirements?

Start at the consultation page. Each track has its own ToR and annexes, plus an official online form link.

Does this only accept EU Member State institutions?

The context references EU/EEA scope and coordination through EU-level public-health systems. Use the official wording in each topic ToR for definitive national and territorial interpretation.

What to do in the next 72 hours

If you are already in public-health infrastructure and can assign a full owner, begin now:

1. Pick one pathogen topic and review its Terms of Reference.
2. Register internal contacts for legal, grant administration, laboratory lead, and quality lead.
3. Ask your national competent authority whether a formal endorsement path is available and what documents they require.
4. Build one-page summary of responsibilities, then map every task to resources.
5. Review deadlines with internal governance so the final deadline date is respected at submission level, not just internal draft level.

This is a heavy but highly strategic filing. Even one strong, credible EURL application can position your institution for sustained EU visibility in pathogen coordination and cross-border public-health operations.